Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (281-290 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|August 15, 2018
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and InvasionRamona Schulz-Heddergott, Nadine Stark, Shelley J Edmunds, et al.
Cancer Cell|May 29, 2018
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress ToleranceNobuaki Takahashi, Hsing-Yu Chen, Isaac S Harris, et al.
Cancer Cell|February 14, 2006
Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterationsBrian B Haines, Chun Jeih Ryu, Sandy Chang, et al.
Cancer Cell|January 18, 2006
Is Cyclin D1-CDK4 kinase a bona fide cancer target?Marcos Malumbres, Mariano Barbacid
Cancer Cell|January 18, 2006
Fly Src: the Yin and Yang of tumor invasion and tumor suppressionG Steven Martin
Cancer Cell|January 18, 2006
Requirement for CDK4 kinase function in breast cancerQunyan Yu, Ewa Sicinska, Yan Geng, et al.
Cancer Cell|April 14, 2010
Prostate cancer: beta control your hormonesMassimo Loda, William G Kaelin
Cancer Cell|August 15, 2006
Co-opted integrin signaling in ErbB2-induced mammary tumor progressionKermit L Carraway, Colleen Sweeney
Cancer Cell|August 15, 2006
An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeriaJaan-Olle Andressoo, James R Mitchell, Jan de Wit, et al.
Cancer Cell|August 4, 2009
Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorderKatherine I Oravecz-Wilson, Steven T Philips, Omer H Yilmaz, et al.
Pageof 410

Showing results (281-290 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|August 15, 2018
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and InvasionRamona Schulz-Heddergott, Nadine Stark, Shelley J Edmunds, et al.
Cancer Cell|May 29, 2018
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress ToleranceNobuaki Takahashi, Hsing-Yu Chen, Isaac S Harris, et al.
Cancer Cell|February 14, 2006
Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterationsBrian B Haines, Chun Jeih Ryu, Sandy Chang, et al.
Cancer Cell|January 18, 2006
Is Cyclin D1-CDK4 kinase a bona fide cancer target?Marcos Malumbres, Mariano Barbacid
Cancer Cell|January 18, 2006
Fly Src: the Yin and Yang of tumor invasion and tumor suppressionG Steven Martin
Cancer Cell|January 18, 2006
Requirement for CDK4 kinase function in breast cancerQunyan Yu, Ewa Sicinska, Yan Geng, et al.
Cancer Cell|April 14, 2010
Prostate cancer: beta control your hormonesMassimo Loda, William G Kaelin
Cancer Cell|August 15, 2006
Co-opted integrin signaling in ErbB2-induced mammary tumor progressionKermit L Carraway, Colleen Sweeney
Cancer Cell|August 15, 2006
An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeriaJaan-Olle Andressoo, James R Mitchell, Jan de Wit, et al.
Cancer Cell|August 4, 2009
Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorderKatherine I Oravecz-Wilson, Steven T Philips, Omer H Yilmaz, et al.
Pageof 410